The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1247
November 6, 2006
View Complete Issue         Table of Contents 2019 
Treatment of Clostridium difficile-Associated Disease (CDAD)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Treatment of Clostridium difficile-Associated Disease (CDAD)
November 6, 2006 (Issue: 1247)
The gram-positive anaerobic bacillus Clostridium difficile is the most common identifiable cause of antibiotic-associated diarrhea. The antibiotics most often implicated have been ampicillin, second and third generation cephalosporins, clindamycin...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Treatment of Clostridium difficile-Associated Disease (CDAD)
Article code: 1247a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.